15 results
8-K
EX-3.2
THRX
Theseus Pharmaceuticals Inc
14 Feb 24
Completion of Acquisition or Disposition of Assets
10:44am
member reasonably believes are within such other person’s professional or expert competence and who has been selected with reasonable care
PRE 14A
THRX
Theseus Pharmaceuticals Inc
14 Apr 23
Preliminary proxy
9:00am
that Ms. Yi qualifies as an audit committee financial expert within the meaning of SEC regulations and meets the financial sophistication requirements … of our audit committee and our Board of Directors, and her designation as audit committee financial expert pursuant to this SEC requirement does
DEF 14A
THRX
Theseus Pharmaceuticals Inc
25 Apr 22
Definitive proxy
4:30pm
statements. Our Board of Directors has determined that Ms. Yi qualifies as an audit committee financial expert within the meaning of SEC regulations … financial expert pursuant to this SEC requirement does not affect the duties, obligations or liability of any other member of our audit committee or our
10-Q
EX-3.1
zt9r ogzidqplnaz6qx
15 Nov 21
Quarterly report
7:36am
424B4
ywsgnvjk9g7bdtowmo9
7 Oct 21
Prospectus supplement with pricing info
5:03pm
S-1/A
EX-3.4
oyshg5kgc qy
30 Sep 21
IPO registration (amended)
6:33am
S-1/A
EX-10.1
dkw4es8 gmz2
30 Sep 21
IPO registration (amended)
6:33am
S-1/A
b6vj4 emo
30 Sep 21
IPO registration (amended)
6:33am
S-1
qjyfznxud 0wzy1sdasu
15 Sep 21
IPO registration
4:04pm
S-1
EX-10.6
qfht5hs0x
15 Sep 21
IPO registration
4:04pm
DRS/A
n2g8as8j
23 Aug 21
Draft registration statement (amended)
12:00am
DRS
qvvya6
20 Jul 21
Draft registration statement
12:00am
DRS
EX-10.6
11ayrfs7r r5c
20 Jul 21
Draft registration statement
12:00am
- Prev
- 1
- Next